GLPwatch
Mounjaro vs Trulicity
Drug comparison
Last updated 2026-05-28 15:46 UTCMounjaro (tirzepatide) and Trulicity (dulaglutide) are both injectable medications made by Eli Lilly for type 2 diabetes. Mounjaro is approved only for diabetes, while Trulicity is also approved to lower cardiovascular risk. Both are given as weekly shots under the skin, but they contain different active ingredients.
AI summary of the sources below.
| Mounjaro | Trulicity | |
|---|---|---|
| Active ingredient | tirzepatide | dulaglutide |
| Manufacturer | eli-lilly | eli-lilly |
| Route | subcutaneous injection | subcutaneous injection |
| FDA-approved for | type 2 diabetes | type 2 diabetes, cardiovascular risk reduction |
| Label updated | 2026-04-22 | 2023-08-05 |